Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
TransparentAI: High-Accuracy and Explainable Melanoma Classification System Björn Friedrich Carl von Ossietzky University, Medicine and Health Sciences, Department of Health Services Research, Division for Assistance Systems and Medical Device Technology PLCO Jul 15, 2024 PLCO-1623
Transportation of Diagnostic Accuracy Measures to a New Target Population Bing Li Brown University NLST Sep 20, 2020 NLST-712
Transporting a prediction model to a new cohort with a novel resampling method Lei Song George Washington University NLST Jan 9, 2024 NLST-1182
Treatment effect in a proportional hazards model with instrumental variables lorenzo tedesco KU LEUVEN HIPB Dec 5, 2022 HIPB-10
Treatment effect on the Survival Time of Lung Cancer Patients Jing Zhou Department of Family and Preventive Medicine PLCO Feb 27, 2020 PLCO-591
Trichomonosis and prostate cancer risk in the Prostate, Lung, Colorectal & Ovarian Cancer Screening Trial Siobhan Sutcliffe Washington University PLCO Nov 9, 2009 2009-0556
Trustworthy Deep Learning Models for Calcification Assessment in Radiotherapy CT using NLST Data Ivana Isgum Amsterdam University Medical Center NLST Dec 4, 2024 NLST-1362
TTFC and COPD in PLCO Neil Caporaso NCI, DCEG, GEB PLCO May 22, 2013 PLCO-36
Tuberculosis and Scarring as Risk Factors for Lung Cancer Eric Engels NCI, DCEG, VEB PLCO Jul 1, 2006 2006-0078
Tumor early detection and prognosis Hongtu Zhu University of Texas MD Anderson Cancer Center NLST Nov 3, 2016 NLST-254
Tumor infiltrating lymphocytes in colorectal cancer Andrew Chan Massachusetts General Hospital and Harvard Medical School PLCO Jun 16, 2016 2016-0012
Two-phase designs with failure time processes subject to non-susceptibility Li Cheung Li Chien Cheung PLCO May 30, 2023 PLCO-1238
Type 1 and Type 2 ovarian cancer in the PLCO Trial Keith Terada University of Hawaii PLCO Nov 4, 2014 PLCO-115
Types of Physical Activity, Sedentary Behavior and Risk of Cancer and Mortality: Pooled Analyses in the NCI Cohort Consortium Steven Moore National Cancer Institute PLCO Feb 26, 2024 PLCO-1483
Ultra-Low-Dose Lung Nodule CT Surveillance Using Prior-Image-Based Reconstruction Hao Zhang Johns Hopkins University NLST Aug 3, 2017 NLST-329
Ultraprocessed Food consumption and Dietary Antioxidant index and incident of Lung Cancer among adult population of US: Evidence from Prostate, Lung, Colorectal and Ovarian Cancers Trial Tefera Mekonnen The University of Adelaide PLCO May 23, 2022 PLCO-982
Uncovering roles of polyunsaturated fatty acids (PUFA) in pancreatic cancer etiology: a gene-diet interaction study Lang Wu University of Hawaii at Manoa PLCO Jan 27, 2020 PLCO-573
Underlying risk of developing and dying from lung cancer Louise Henderson University of North Carolina at Chapel Hill NLST May 16, 2024 NLST-1248
Understanding comorbidities that contribute to drug response in ovarian cancer Sara Cooper HudsonAlpha Institute for Biotechnology PLCO Apr 13, 2018 PLCO-362
Understanding Factors Related to Prostate, Lung, and Colorectal Cancer Screening Among African American Men Marvella Ford Medical University of South Carolina Hollings Cancer Center PLCO Jul 1, 2006 2006-0089